nodes	percent_of_prediction	percent_of_DWPC	metapath
Droperidol—Fenbufen—Balsalazide—Crohn's disease	0.978	1	CrCrCtD
Droperidol—HTR2A—enteric nervous system—Crohn's disease	0.00892	0.451	CbGeAlD
Droperidol—HTR2A—myenteric nerve plexus—Crohn's disease	0.00676	0.342	CbGeAlD
Droperidol—ADRA1A—epithelium—Crohn's disease	0.00104	0.0526	CbGeAlD
Droperidol—ADRA1A—lymphoid tissue—Crohn's disease	0.000802	0.0405	CbGeAlD
Droperidol—HTR2A—epithelium—Crohn's disease	0.000673	0.034	CbGeAlD
Droperidol—HTR2A—smooth muscle tissue—Crohn's disease	0.000648	0.0328	CbGeAlD
Droperidol—HTR2A—digestive system—Crohn's disease	0.000512	0.0259	CbGeAlD
Droperidol—KCNH2—lymph node—Crohn's disease	0.000437	0.0221	CbGeAlD
Droperidol—KCNH2—Hematopoietic Stem Cell Differentiation—IKZF1—Crohn's disease	0.000211	0.0912	CbGpPWpGaD
Droperidol—HTR2A—Serotonin Receptor 2 and STAT3 Signaling—JAK2—Crohn's disease	0.000117	0.0506	CbGpPWpGaD
Droperidol—HTR2A—Serotonin Receptor 2 and STAT3 Signaling—STAT3—Crohn's disease	8.59e-05	0.0371	CbGpPWpGaD
Droperidol—KCNH2—Hematopoietic Stem Cell Differentiation—IL3—Crohn's disease	7.27e-05	0.0314	CbGpPWpGaD
Droperidol—HTR2A—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—RASGRP1—Crohn's disease	6.64e-05	0.0287	CbGpPWpGaD
Droperidol—KCNH2—SIDS Susceptibility Pathways—CREM—Crohn's disease	6.5e-05	0.0281	CbGpPWpGaD
Droperidol—HTR2A—SIDS Susceptibility Pathways—CREM—Crohn's disease	3.52e-05	0.0152	CbGpPWpGaD
Droperidol—HTR2A—G alpha (q) signalling events—MLN—Crohn's disease	3.33e-05	0.0144	CbGpPWpGaD
Droperidol—ADRA1A—G alpha (q) signalling events—MLN—Crohn's disease	3.26e-05	0.0141	CbGpPWpGaD
Droperidol—KCNH2—Hematopoietic Stem Cell Differentiation—IL1B—Crohn's disease	3e-05	0.013	CbGpPWpGaD
Droperidol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—MLN—Crohn's disease	2.98e-05	0.0129	CbGpPWpGaD
Droperidol—DRD2—Circadian rythm related genes—CREM—Crohn's disease	2.92e-05	0.0126	CbGpPWpGaD
Droperidol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MLN—Crohn's disease	2.92e-05	0.0126	CbGpPWpGaD
Droperidol—DRD2—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	2.76e-05	0.0119	CbGpPWpGaD
Droperidol—HTR2A—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	2.72e-05	0.0117	CbGpPWpGaD
Droperidol—ADRA1A—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	2.66e-05	0.0115	CbGpPWpGaD
Droperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	2.37e-05	0.0102	CbGpPWpGaD
Droperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	2.33e-05	0.0101	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	2.28e-05	0.00985	CbGpPWpGaD
Droperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	2.24e-05	0.00969	CbGpPWpGaD
Droperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	2.21e-05	0.00954	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	2.16e-05	0.00934	CbGpPWpGaD
Droperidol—HTR2A—G alpha (q) signalling events—GPR65—Crohn's disease	2.15e-05	0.00928	CbGpPWpGaD
Droperidol—ADRA1A—G alpha (q) signalling events—GPR65—Crohn's disease	2.1e-05	0.00908	CbGpPWpGaD
Droperidol—DRD2—G alpha (i) signalling events—CCR9—Crohn's disease	1.96e-05	0.00845	CbGpPWpGaD
Droperidol—KCNH2—SIDS Susceptibility Pathways—IL10—Crohn's disease	1.92e-05	0.00831	CbGpPWpGaD
Droperidol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—Crohn's disease	1.92e-05	0.0083	CbGpPWpGaD
Droperidol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—Crohn's disease	1.88e-05	0.00813	CbGpPWpGaD
Droperidol—DRD2—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	1.82e-05	0.00784	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—ACKR2—Crohn's disease	1.8e-05	0.00778	CbGpPWpGaD
Droperidol—HTR2A—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	1.79e-05	0.00771	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—ACKR2—Crohn's disease	1.77e-05	0.00766	CbGpPWpGaD
Droperidol—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—Crohn's disease	1.76e-05	0.00758	CbGpPWpGaD
Droperidol—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	1.75e-05	0.00755	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—ACKR2—Crohn's disease	1.74e-05	0.0075	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—MLN—Crohn's disease	1.71e-05	0.00738	CbGpPWpGaD
Droperidol—DRD2—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	1.69e-05	0.00729	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—MLN—Crohn's disease	1.68e-05	0.00726	CbGpPWpGaD
Droperidol—HTR2A—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	1.66e-05	0.00717	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—MLN—Crohn's disease	1.65e-05	0.00711	CbGpPWpGaD
Droperidol—ADRA1A—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	1.63e-05	0.00702	CbGpPWpGaD
Droperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	1.56e-05	0.00672	CbGpPWpGaD
Droperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	1.53e-05	0.00661	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	1.5e-05	0.00647	CbGpPWpGaD
Droperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	1.45e-05	0.00624	CbGpPWpGaD
Droperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	1.42e-05	0.00614	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	1.39e-05	0.00602	CbGpPWpGaD
Droperidol—DRD2—G alpha (i) signalling events—CCR6—Crohn's disease	1.3e-05	0.0056	CbGpPWpGaD
Droperidol—DRD2—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	1.2e-05	0.00519	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—CCR9—Crohn's disease	1.18e-05	0.00512	CbGpPWpGaD
Droperidol—HTR2A—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	1.18e-05	0.00511	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—CCR9—Crohn's disease	1.17e-05	0.00503	CbGpPWpGaD
Droperidol—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	1.16e-05	0.005	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—CCR9—Crohn's disease	1.14e-05	0.00493	CbGpPWpGaD
Droperidol—HTR2A—G alpha (q) signalling events—RASGRP1—Crohn's disease	1.11e-05	0.00479	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—GPR65—Crohn's disease	1.1e-05	0.00476	CbGpPWpGaD
Droperidol—ADRA1A—G alpha (q) signalling events—RASGRP1—Crohn's disease	1.09e-05	0.00469	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—GPR65—Crohn's disease	1.08e-05	0.00468	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—GPR65—Crohn's disease	1.06e-05	0.00458	CbGpPWpGaD
Droperidol—DRD2—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	1.06e-05	0.00457	CbGpPWpGaD
Droperidol—KCNH2—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	1.05e-05	0.00454	CbGpPWpGaD
Droperidol—HTR2A—SIDS Susceptibility Pathways—IL10—Crohn's disease	1.04e-05	0.0045	CbGpPWpGaD
Droperidol—HTR2A—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	1.04e-05	0.0045	CbGpPWpGaD
Droperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	1.03e-05	0.00445	CbGpPWpGaD
Droperidol—ADRA1A—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	1.02e-05	0.00441	CbGpPWpGaD
Droperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	1.01e-05	0.00438	CbGpPWpGaD
Droperidol—KCNH2—SIDS Susceptibility Pathways—IL1B—Crohn's disease	1.01e-05	0.00436	CbGpPWpGaD
Droperidol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—Crohn's disease	9.93e-06	0.00429	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	9.92e-06	0.00429	CbGpPWpGaD
Droperidol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—Crohn's disease	9.72e-06	0.0042	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—MLN—Crohn's disease	9.65e-06	0.00417	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—MLN—Crohn's disease	9.5e-06	0.0041	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—MLN—Crohn's disease	9.3e-06	0.00402	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—ACKR2—Crohn's disease	9.25e-06	0.00399	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—ACKR2—Crohn's disease	9.1e-06	0.00393	CbGpPWpGaD
Droperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	9.07e-06	0.00392	CbGpPWpGaD
Droperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	8.92e-06	0.00385	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—ACKR2—Crohn's disease	8.91e-06	0.00385	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—MLN—Crohn's disease	8.77e-06	0.00379	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	8.74e-06	0.00377	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—MLN—Crohn's disease	8.63e-06	0.00373	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—MLN—Crohn's disease	8.45e-06	0.00365	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—CCR6—Crohn's disease	7.84e-06	0.00339	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—CCR6—Crohn's disease	7.72e-06	0.00333	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—CCR6—Crohn's disease	7.56e-06	0.00326	CbGpPWpGaD
Droperidol—KCNH2—SIDS Susceptibility Pathways—TNF—Crohn's disease	7.32e-06	0.00316	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—PTGER4—Crohn's disease	6.91e-06	0.00298	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—PTGER4—Crohn's disease	6.8e-06	0.00294	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—CCR9—Crohn's disease	6.69e-06	0.00289	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—PTGER4—Crohn's disease	6.65e-06	0.00287	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—CCR9—Crohn's disease	6.58e-06	0.00284	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—CCR9—Crohn's disease	6.45e-06	0.00279	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—GPR65—Crohn's disease	6.22e-06	0.00269	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—GPR65—Crohn's disease	6.12e-06	0.00264	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—CCR9—Crohn's disease	6.08e-06	0.00263	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—GPR65—Crohn's disease	5.99e-06	0.00259	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—CCR9—Crohn's disease	5.98e-06	0.00258	CbGpPWpGaD
Droperidol—KCNH2—SIDS Susceptibility Pathways—IL6—Crohn's disease	5.91e-06	0.00255	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—CCR9—Crohn's disease	5.86e-06	0.00253	CbGpPWpGaD
Droperidol—HTR2A—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	5.7e-06	0.00246	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—GPR65—Crohn's disease	5.65e-06	0.00244	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—GPR65—Crohn's disease	5.56e-06	0.0024	CbGpPWpGaD
Droperidol—HTR2A—SIDS Susceptibility Pathways—IL1B—Crohn's disease	5.47e-06	0.00236	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ACKR2—Crohn's disease	5.46e-06	0.00236	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—GPR65—Crohn's disease	5.44e-06	0.00235	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ACKR2—Crohn's disease	5.38e-06	0.00232	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ACKR2—Crohn's disease	5.26e-06	0.00227	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MLN—Crohn's disease	5.18e-06	0.00224	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MLN—Crohn's disease	5.1e-06	0.0022	CbGpPWpGaD
Droperidol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	5.07e-06	0.00219	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MLN—Crohn's disease	4.99e-06	0.00216	CbGpPWpGaD
Droperidol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	4.96e-06	0.00214	CbGpPWpGaD
Droperidol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	4.83e-06	0.00209	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—TAGAP—Crohn's disease	4.74e-06	0.00205	CbGpPWpGaD
Droperidol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	4.73e-06	0.00204	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—TAGAP—Crohn's disease	4.66e-06	0.00201	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—TAGAP—Crohn's disease	4.56e-06	0.00197	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—CCR6—Crohn's disease	4.43e-06	0.00191	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—CCR6—Crohn's disease	4.36e-06	0.00188	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—CCR6—Crohn's disease	4.27e-06	0.00184	CbGpPWpGaD
Droperidol—DRD2—G alpha (i) signalling events—CXCL8—Crohn's disease	4.17e-06	0.0018	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—RSPO3—Crohn's disease	4.14e-06	0.00179	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—RSPO3—Crohn's disease	4.07e-06	0.00176	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—CCR6—Crohn's disease	4.03e-06	0.00174	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—RSPO3—Crohn's disease	3.99e-06	0.00172	CbGpPWpGaD
Droperidol—HTR2A—SIDS Susceptibility Pathways—TNF—Crohn's disease	3.97e-06	0.00171	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—CCR6—Crohn's disease	3.96e-06	0.00171	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—SEL1L—Crohn's disease	3.93e-06	0.0017	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—PTGER4—Crohn's disease	3.9e-06	0.00169	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—CCR6—Crohn's disease	3.88e-06	0.00168	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—SEL1L—Crohn's disease	3.86e-06	0.00167	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—PTGER4—Crohn's disease	3.84e-06	0.00166	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—SEL1L—Crohn's disease	3.78e-06	0.00163	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—PTGER4—Crohn's disease	3.76e-06	0.00162	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CCR9—Crohn's disease	3.59e-06	0.00155	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—PTGER4—Crohn's disease	3.54e-06	0.00153	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CCR9—Crohn's disease	3.53e-06	0.00153	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—PTGER4—Crohn's disease	3.49e-06	0.00151	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CCR9—Crohn's disease	3.46e-06	0.00149	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—PTGER4—Crohn's disease	3.41e-06	0.00147	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—GPR65—Crohn's disease	3.34e-06	0.00144	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—IL3—Crohn's disease	3.32e-06	0.00144	CbGpPWpGaD
Droperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	3.32e-06	0.00143	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—GPR65—Crohn's disease	3.28e-06	0.00142	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—IL3—Crohn's disease	3.27e-06	0.00141	CbGpPWpGaD
Droperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	3.27e-06	0.00141	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—GPR65—Crohn's disease	3.22e-06	0.00139	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—RASGRP1—Crohn's disease	3.22e-06	0.00139	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—IL3—Crohn's disease	3.2e-06	0.00138	CbGpPWpGaD
Droperidol—HTR2A—SIDS Susceptibility Pathways—IL6—Crohn's disease	3.2e-06	0.00138	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	3.2e-06	0.00138	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—RASGRP1—Crohn's disease	3.16e-06	0.00137	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—RASGRP1—Crohn's disease	3.1e-06	0.00134	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—IL3—Crohn's disease	3.02e-06	0.0013	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—IL3—Crohn's disease	2.97e-06	0.00128	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—RASGRP1—Crohn's disease	2.92e-06	0.00126	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—IL3—Crohn's disease	2.91e-06	0.00126	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—RASGRP1—Crohn's disease	2.87e-06	0.00124	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—RASGRP1—Crohn's disease	2.81e-06	0.00122	CbGpPWpGaD
Droperidol—DRD2—Circadian rythm related genes—IL6—Crohn's disease	2.66e-06	0.00115	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—CXCL8—Crohn's disease	2.53e-06	0.00109	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—CXCL8—Crohn's disease	2.49e-06	0.00107	CbGpPWpGaD
Droperidol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	2.48e-06	0.00107	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—CXCL8—Crohn's disease	2.44e-06	0.00105	CbGpPWpGaD
Droperidol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	2.43e-06	0.00105	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CCR6—Crohn's disease	2.38e-06	0.00103	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CCR6—Crohn's disease	2.34e-06	0.00101	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—IL2RA—Crohn's disease	2.33e-06	0.00101	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—IL2RA—Crohn's disease	2.29e-06	0.00099	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CCR6—Crohn's disease	2.29e-06	0.00099	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—IL2RA—Crohn's disease	2.24e-06	0.000969	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—RBX1—Crohn's disease	2.15e-06	0.000929	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—RBX1—Crohn's disease	2.12e-06	0.000914	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—IL2RA—Crohn's disease	2.11e-06	0.000913	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PTGER4—Crohn's disease	2.09e-06	0.000904	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—IL2RA—Crohn's disease	2.08e-06	0.000899	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—RBX1—Crohn's disease	2.07e-06	0.000895	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PTGER4—Crohn's disease	2.06e-06	0.00089	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—IL2RA—Crohn's disease	2.04e-06	0.00088	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PTGER4—Crohn's disease	2.02e-06	0.000871	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—UBE2D1—Crohn's disease	1.89e-06	0.000815	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—UBE2D1—Crohn's disease	1.86e-06	0.000802	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—RIPK2—Crohn's disease	1.83e-06	0.00079	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—UBE2D1—Crohn's disease	1.82e-06	0.000785	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—RIPK2—Crohn's disease	1.8e-06	0.000777	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IL3—Crohn's disease	1.78e-06	0.00077	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—RIPK2—Crohn's disease	1.76e-06	0.000761	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IL3—Crohn's disease	1.75e-06	0.000758	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—RASGRP1—Crohn's disease	1.72e-06	0.000745	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IL3—Crohn's disease	1.72e-06	0.000742	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—RASGRP1—Crohn's disease	1.7e-06	0.000733	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—RASGRP1—Crohn's disease	1.66e-06	0.000718	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—JAK2—Crohn's disease	1.57e-06	0.000676	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—SOCS1—Crohn's disease	1.56e-06	0.000675	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—JAK2—Crohn's disease	1.54e-06	0.000665	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—SOCS1—Crohn's disease	1.54e-06	0.000664	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—JAK2—Crohn's disease	1.51e-06	0.000651	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—SOCS1—Crohn's disease	1.51e-06	0.00065	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—TYK2—Crohn's disease	1.49e-06	0.000644	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—TYK2—Crohn's disease	1.47e-06	0.000633	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—TYK2—Crohn's disease	1.44e-06	0.00062	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—CXCL8—Crohn's disease	1.43e-06	0.000617	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—JAK2—Crohn's disease	1.42e-06	0.000614	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—CXCL8—Crohn's disease	1.41e-06	0.000607	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—JAK2—Crohn's disease	1.4e-06	0.000604	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—CXCL8—Crohn's disease	1.38e-06	0.000595	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—JAK2—Crohn's disease	1.37e-06	0.000592	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—SMAD3—Crohn's disease	1.35e-06	0.000583	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—SMAD3—Crohn's disease	1.33e-06	0.000573	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—SMAD3—Crohn's disease	1.3e-06	0.000561	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—CXCL8—Crohn's disease	1.3e-06	0.00056	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—CXCL8—Crohn's disease	1.28e-06	0.000551	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—CXCL8—Crohn's disease	1.25e-06	0.00054	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IL2RA—Crohn's disease	1.25e-06	0.00054	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IL2RA—Crohn's disease	1.23e-06	0.000531	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IL2RA—Crohn's disease	1.2e-06	0.00052	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—TYK2—Crohn's disease	8.8e-07	0.00038	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—TYK2—Crohn's disease	8.66e-07	0.000374	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—TYK2—Crohn's disease	8.48e-07	0.000366	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—JAK2—Crohn's disease	8.4e-07	0.000363	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—JAK2—Crohn's disease	8.26e-07	0.000357	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—JAK2—Crohn's disease	8.09e-07	0.000349	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CXCL8—Crohn's disease	7.66e-07	0.000331	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CXCL8—Crohn's disease	7.54e-07	0.000326	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CXCL8—Crohn's disease	7.38e-07	0.000319	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—IL6—Crohn's disease	7.29e-07	0.000315	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—IL6—Crohn's disease	7.17e-07	0.00031	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—IL6—Crohn's disease	7.02e-07	0.000303	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—STAT3—Crohn's disease	6.16e-07	0.000266	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—STAT3—Crohn's disease	6.06e-07	0.000262	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—STAT3—Crohn's disease	5.94e-07	0.000256	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IL6—Crohn's disease	4.3e-07	0.000186	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IL6—Crohn's disease	4.24e-07	0.000183	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IL6—Crohn's disease	4.15e-07	0.000179	CbGpPWpGaD
